Sep 18 2024 |
White House and USTR Announce Changes to De Minimis Exception and Section 301 Tariffs |
Greenberg Traurig, LLP |
Sep 18 2024 |
Final Mental Health Parity Rules – Top Five Changes to the Status Quo |
Foley & Lardner LLP |
Sep 18 2024 |
Firms Fails to File 13Fs, Fines Follow |
K&L Gates LLP |
Sep 18 2024 |
Supreme Court to Determine Whether Retirees Can Claim Disability Discrimination in Benefits |
Ogletree, Deakins, Nash, Smoak & Stewart, P.C. |
Sep 18 2024 |
United States Government Accountability Office Finds Federal Contracting Rules do not Prohibit Labor Harmony Agreement Requirements |
Proskauer Rose LLP |
Sep 18 2024 |
Four Strategies and Five Legal Arguments To Defend Your Company Against EPA’s Benzene Enforcement Initiative |
Beveridge & Diamond PC |
Sep 18 2024 |
OSHA Proposes New Heat Injury and Illness Prevention Standard |
Beveridge & Diamond PC |
Sep 18 2024 |
Cybersecurity for Employee Benefit Plans: Updated EBSA Guidance |
Varnum LLP |
Sep 17 2024 |
OECD Publishes Synthesis Report on Understanding Perfluoropolyethers and Their Life Cycle |
Bergeson & Campbell, P.C. |
Sep 17 2024 |
Energy Tax Credits for a New World Part VII: Low-Income Communities Bonus Credits |
ASKramer Law |
Sep 17 2024 |
End of Summer Pool Party: CFTC Approves Final Rule Amending 4.7 Regulatory Relief for CPOs and CTAs |
K&L Gates LLP |
Sep 17 2024 |
Ubrelvy Untitled Letter – A Double Fault for AbbVie? Or Makeup Misread for FDA? |
Sheppard, Mullin, Richter & Hampton LLP |
Sep 17 2024 |
SEC “Greenwashing” Enforcement Case Against Public Company |
Proskauer Rose LLP |
Sep 17 2024 |
Corporate Transparency Act (CTA): Action Required for Community Associations |
Stark & Stark |
Sep 17 2024 |
Regulators Ramp up Scrutiny of Games’ Business Models |
Sheppard, Mullin, Richter & Hampton LLP |
Sep 17 2024 |
FDA and the Fountain of Youth: Regulatory Hurdles in the Longevity Biotech Community |
Womble Bond Dickinson (US) LLP |
Sep 17 2024 |
Unlocking the Benefits of U.S. Citizenship |
Berry Appleman & Leiden |
Sep 17 2024 |
Manufacturer Acted Reasonably in Terminating a Franchisee for Failure to Abide by Agreement |
Foley & Lardner LLP |
Sep 17 2024 |
What U.S. Companies Can Expect from the US—International Framework Convention on AI |
Nelson Mullins |
Sep 17 2024 |
NLRB Regional Director Targets No-Poach Agreements in Latest Complaint |
Proskauer Rose LLP |
Sep 17 2024 |
How Whistleblowers Can Report Fraud, Waste, and Abuse: Recent GAO Testimony Explained |
Tycko & Zavareei LLP |
Sep 17 2024 |
White House Asks Public, Private Sectors to Commit by Nov. 1 to Quell Effects of Extreme Heat |
Barnes & Thornburg LLP |
Sep 17 2024 |
Final Mental Health Parity Regulations Released, with Plan Sponsor Action Required by 2025 |
Proskauer Rose LLP |
Sep 17 2024 |
Foley Automotive Update 17 September 2024 |
Foley & Lardner LLP |
Sep 17 2024 |
How to Effectively Use Social Media Advocacy Tools and Why They Shouldn’t Be Your Only Strategy |
Stefanie Marrone Consulting |
Sep 17 2024 |
The 340B Drug Pricing Program: Top Five Things to Know |
Foley & Lardner LLP |
Sep 17 2024 |
Corporate Transparency Act: January 1, 2025 Filing Deadline and Recent Developments |
Katten |
Sep 17 2024 |
The Sunset of the Doubled Estate, Gift, and GST Tax Exclusion Amounts After December 31, 2025 |
ArentFox Schiff LLP |
Sep 17 2024 |
White House Launches ‘Time Is Money’ Initiative |
McDermott Will & Schulte LLP |
Sep 17 2024 |
NCC Requests Extra Time to Comment on FSIS Salmonella Rule |
Keller and Heckman LLP |
Sep 16 2024 |
Update: Supreme Court Revises Title VII’s Decades-Old “Adverse Employment Action” Standard for Discriminatory Transfers |
Foley & Lardner LLP |
Sep 16 2024 |
Shifting Views on Paid Administrative Leave |
Foley & Lardner LLP |
Sep 16 2024 |
Emergency Congressional Action Needed to Save CFTC Whistleblower Program |
Kohn, Kohn & Colapinto |
Sep 16 2024 |
Healthcare Preview for the Week of: September 16, 2024 [Podcast] |
McDermott Will & Schulte LLP |
Sep 16 2024 |
NLRB General Counsel Tries to Reconcile FERPA and the NLRA |
Robinson & Cole LLP |